R1 RCM's (RCM) Outperform Rating Reaffirmed at Royal Bank of Canada
Royal Bank of Canada restated their outperform rating on shares of R1 RCM (NASDAQ:RCM – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $19.00 target price on the healthcare provider’s stock. A number of other equities analysts also recently weighed in on the company. KeyCorp dropped their target […]